Table 1.
The characteristics of the trial groups
| Characteristics | None | Maxbelt |
|---|---|---|
| Number | 38 | 39 |
| Age | ||
| Mean ± SD, years | 56.24 ± 11.47 | 51.31 ± 10.13 |
| ≥45 years | 30 (78.9%) | 32 (82.1%) |
| Gender, male | 25 (65.8%) | 24 (61.5%) |
| Body height, mean ± SD, cm | 166.15 ± 9.75 | 166.51 ± 8.86 |
| Body weight, mean ± SD, kg | 68.93 ± 18.8 | 72.85 ± 16.13 |
| Body mass index | 24.68 ± 5.33 | 26.06 ± 4.36 |
| Mean ± SD, kg/m2 | ||
| <18.5 | 9 (23.7%) | 6 (15.4%) |
| 18.5–25 | 5 (13.2%) | 2 (5.1%) |
| ≥25 | 24 (63.1%) | 31 (79.5%) |
| Colonoscopy indication | ||
| Evaluation of symptoms | 9 (23.7%) | 14 (35.9%) |
| Screening | 21 (55.3%) | 19 (48.7%) |
| Polyp surveillance | 8 (21.0%) | 6 (15.4%) |
| Type of colonoscope | ||
| CF‐HQ290 | 32 (84.2%) | 36 (92.3%) |
| PCF‐H290H | 6 (15.8%) | 3 (7.7%) |
| Preparation | ||
| A | 21 (55.3%) | 19 (48.7%) |
| B | 15 (39.5%) | 17 (43.6%) |
| C | 2 (5.2%) | 3 (7.7%) |
| Previous insertion time ≥ 8 min | 5 | 4 |